Prognostic Value of Systemic Immune-Inflammation Index and NT-proBNP in Patients with Acute ST-Elevation Myocardial Infarction

References

• Bajaj A, Sethi A, Rathor P, Suppogu N, Sethi A. Acute complications of myocardial infarction in the current era: diagnosis and management. J Investig Med. 2015;63(7):844–855. doi:10.1097/jim.0000000000000232
   PubMed Web of Science ®Google Scholar
• Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816. doi:10.1093/eurheartj/ehx095
   PubMed Web of Science ®Google Scholar
• Radwan H, Hussein EM, Refaat H. Short- and long-term prognostic value of right ventricular function in patients with first acute ST elevation myocardial infarction treated by primary angioplasty. Echocardiography. 2021;38(2):249–260. doi:10.1111/echo.14974
   PubMed Web of Science ®Google Scholar
• Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary angiography after cardiac arrest without ST segment elevation: one-year outcomes of the COACT randomized clinical trial. JAMA Cardiol. 2020;5(12):1358–1365. doi:10.1001/jamacardio.2020.3670
   PubMed Web of Science ®Google Scholar
• Otero-García O, Cid-álvarez AB, Juskova M, et al. Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of an 11-year all-comers registry. Eur Heart J Acute Cardiovasc Care. 2021;10:898–908. doi:10.1093/ehjacc/zuab058
   PubMed Web of Science ®Google Scholar
• Huang H, Liu Q, Zhu L, et al. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer. Sci Rep. 2019;9(1):3284. doi:10.1038/s41598-019-39150-0
   PubMed Web of Science ®Google Scholar
• Han Y-C, Yang T-H, Kim D-I, et al. Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J. 2013;43(2):93–99. doi:10.4070/kcj.2013.43.2.93
   PubMed Web of Science ®Google Scholar
• Chen H, Li M, Liu L, Dang X, Zhu D, Tian G. Monocyte/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients with non-ST-elevation myocardial infarction. Medicine. 2019;98(26):e16267. doi:10.1097/md.0000000000016267
   PubMed Web of Science ®Google Scholar
• Clerico A, Vittorini S, Passino C. Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. Clin Chem Lab Med. 2011;49(12):1949–1954. doi:10.1515/cclm.2011.686
   PubMed Web of Science ®Google Scholar
• Yamashita T, Seino Y, Ogawa A, et al. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency. J Cardiol. 2010;55(3):377–383. doi:10.1016/j.jjcc.2010.01.008
   PubMed Web of Science ®Google Scholar
• Emdin M, Passino C, Prontera C, et al. Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure. Clin Chem. 2007;53(7):1289–1297. doi:10.1373/clinchem.2006.080234
   PubMed Web of Science ®Google Scholar
• Schellings DA, Adiyaman A, Dambrink JE, et al. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores. Vasc Health Risk Manag. 2016;12:471–476. doi:10.2147/vhrm.S117204
   PubMedGoogle Scholar
• Scirica BM, Kadakia MB, de Lemos JA, et al. Association between natriuretic peptides and mortality among patients admitted with myocardial infarction: a report from the ACTION registry(R)-GWTG™. Clin Chem. 2013;59:1205–1214. doi:10.1373/clinchem.2012.198556
   PubMed Web of Science ®Google Scholar
• Frampton J, Devries JT, Welch TD, Gersh BJ. Modern management of ST-segment elevation myocardial infarction. Curr Probl Cardiol. 2020;45(3):100393. doi:10.1016/j.cpcardiol.2018.08.005
   PubMed Web of Science ®Google Scholar
• Blondheim DS, Kleiner-Shochat M, Asif A, et al. Characteristics, management, and outcome of transient ST-elevation versus persistent ST-elevation and non-ST-elevation myocardial infarction. Am J Cardiol. 2018;121:1449–1455. doi:10.1016/j.amjcard.2018.02.029
   PubMed Web of Science ®Google Scholar
• Urbinati S, Tonet E. Cardiac rehabilitation after STEMI. Minerva Cardioangiol. 2018;66:464–470. doi:10.23736/s0026-4725.18.04674-1
   PubMed Web of Science ®Google Scholar
• Otten AM, Ottervanger JP, Timmer JR, et al. Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study. Diabetol Metab Syndr. 2013;5(1):34. doi:10.1186/1758-5996-5-34
   PubMedGoogle Scholar
• Lichtman JH, Leifheit EC, Safdar B, et al. Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: evidence from the VIRGO study (variation in recovery: role of gender on outcomes of young AMI patients). Circulation. 2018;137(8):781–790. doi:10.1161/circulationaha.117.031650
   PubMed Web of Science ®Google Scholar
• Candemir M, Kiziltunç E, Nurkoç S, Şahinarslan A. Relationship between Systemic Immune-Inflammation Index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72(6):575–581. doi:10.1177/0003319720987743
   PubMed Web of Science ®Google Scholar
• Hally KE, La Flamme AC, Larsen PD, Harding SA. Platelet toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction. Thromb Res. 2017;158:8–15. doi:10.1016/j.thromres.2017.07.031
   PubMed Web of Science ®Google Scholar
• Hou D, Wang C, Luo Y, et al. Systemic immune-inflammation index (SII) but not platelet-albumin-bilirubin (PALBI) grade is associated with severity of acute ischemic stroke (AIS). Int J Neurosci. 2021;131(12):1203–1208. doi:10.1080/00207454.2020.1784166
   PubMed Web of Science ®Google Scholar
• Su G, Zhang Y, Xiao R, Zhang T, Gong B. Systemic immune-inflammation index as a promising predictor of mortality in patients with acute coronary syndrome: a real-world study. J Int Med Res. 2021;49(5):3000605211016274. doi:10.1177/03000605211016274
   Web of Science ®Google Scholar
• Harm T, Bild A, Dittrich K, et al. Acute coronary syndrome is associated with a substantial change in the platelet lipidome. Cardiovasc Res. 2022;118(8):1904–1916. doi:10.1093/cvr/cvab238
   PubMed Web of Science ®Google Scholar
• Klopf J, Brostjan C, Eilenberg W, Neumayer C. Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease. Int J Mol Sci. 2021;22(2):559. doi:10.3390/ijms22020559
   PubMed Web of Science ®Google Scholar
• Petzold T, Zhang Z, Ballesteros I, et al. Neutrophil “plucking” on megakaryocytes drives platelet production and boosts cardiovascular disease. Immunity. 2022;55(12):2285–2299.e7. doi:10.1016/j.immuni.2022.10.001
   PubMed Web of Science ®Google Scholar
• Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the associations of novel inflammatory biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. Int J Mol Sci. 2022;23(17):9553. doi:10.3390/ijms23179553
   PubMed Web of Science ®Google Scholar
• Cordero A, Martínez Rey-Rañal E, Moreno MJ, et al. Predictive value of Pro-BNP for heart failure readmission after an acute coronary syndrome. J Clin Med. 2021;10(8):1653. doi:10.3390/jcm10081653
   PubMed Web of Science ®Google Scholar
• Schellings DA, Adiyaman A, Giannitsis E, et al. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle risk score. J Am Heart Assoc. 2014;3(6):e001089. doi:10.1161/jaha.114.001089
   PubMed Web of Science ®Google Scholar
• Shanmuganathan M, Masi A, Burrage MK, et al. Acute response in the noninfarcted myocardium predicts long-term major adverse cardiac events after STEMI. JACC Cardiovascular Imaging. 2023;16(1):46–59. doi:10.1016/j.jcmg.2022.09.015
   PubMed Web of Science ®Google Scholar
• Çinar T, Hayiroğlu M, Şeker M, et al. The predictive value of age, creatinine, ejection fraction score for in-hospital mortality in patients with cardiogenic shock. Coron Artery Dis. 2019;30(8):569–574. doi:10.1097/mca.0000000000000776
   PubMed Web of Science ®Google Scholar